Literature DB >> 8605797

Cardiopulmonary manifestations of hantavirus pulmonary syndrome.

G W Hallin1, S Q Simpson, R E Crowell, D S James, F T Koster, G J Mertz, H Levy.   

Abstract

OBJECTIVE: To describe the clinical characteristics of a group of patients infected with the newly recognized hantavirus in the Southwestern United States.
DESIGN: Case series.
SETTING: Tertiary referral center. PATIENTS: All patients with confirmed hantavirus infection admitted to the University of New Mexico Hospital between May 1, 1993 and January 1, 1994.
INTERVENTIONS: Records of patients with hantavirus infection were reviewed to collect all pertinent clinical data.
MEASUREMENTS AND MAIN RESULTS: Pulmonary disease in these patients was characterized by hypoxemia covering a wide range of severity. The cause of hypoxemia was an increased permeability (noncardiac) pulmonary edema which could be differentiated from hydrostatic (cardiac) pulmonary edema by its association with low pulmonary artery occlusion pressures and increased protein content of edema fluid. Hemodynamic measurements in severe cases showed a shock state characterized by a low cardiac index (range 1.6 to 3.0 L/min/min2), a low stroke volume index (range 10.5 to 29 mL/m2), and high systemic vascular resistance index (range 1,653 to 2,997 dyne.sec/cm5.m2). Progression to death was associated with worsening cardiac dysfunction unresponsive to treatment and causing oxygen debt and lactic acidosis.
CONCLUSIONS: The two major life-threatening pathophysiologic changes in Hantavirus Pulmonary Syndrome are increased permeability pulmonary edema, and an atypical form of septic shock caused by myocardial depression and hypovolemia.

Entities:  

Mesh:

Year:  1996        PMID: 8605797     DOI: 10.1097/00003246-199602000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  45 in total

1.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 2.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

3.  Choclo virus infection in the Syrian golden hamster.

Authors:  Eduardo J Eyzaguirre; Mary Louise Milazzo; Frederick T Koster; Charles F Fulhorst
Journal:  Am J Trop Med Hyg       Date:  2008-04       Impact factor: 2.345

4.  Drotrecogin alpha (activated) in two patients with the hantavirus cardiopulmonary syndrome.

Authors:  Robert C McDermid; R T Noel Gibney; Ronald J Brisebois; Neil M Skjodt
Journal:  Can Respir J       Date:  2006 Jul-Aug       Impact factor: 2.409

5.  Phage display selection of cyclic peptides that inhibit Andes virus infection.

Authors:  Pamela R Hall; Brian Hjelle; Hadya Njus; Chunyan Ye; Virginie Bondu-Hawkins; David C Brown; Kathleen A Kilpatrick; Richard S Larson
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

6.  The detection of vascular endothelial growth factor in serum of patients with hemorrhagic fever with renal syndrome.

Authors:  Man Li; Yuqiang Ji; Yanying Dong; Yan Zhou; Huixun Ren; Ming Xie
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  Hantavirus infection with marked sinus bradycardia, Taiwan.

Authors:  Yuan-Hong Liu; Jyh-Hsiung Huang; Po-Ren Hsueh; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

8.  Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells.

Authors:  Elena E Gorbunova; Irina N Gavrilovskaya; Erich R Mackow
Journal:  Antiviral Res       Date:  2013-05-20       Impact factor: 5.970

9.  Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.

Authors:  Ian C Davis; Allan J Zajac; Kurt B Nolte; Jason Botten; Brian Hjelle; Sadis Matalon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  First human isolate of Hantavirus (Andes virus) in the Americas.

Authors:  Hector Galeno; Judith Mora; Eliecer Villagra; Jorge Fernandez; Jury Hernandez; Gregory J Mertz; Eugenio Ramirez
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.